These technologies offer promising alternatives to failing antibiotics, especially against pathogens with complex resistance mechanisms, however, limitations include toxicity concerns, immunological variability, immunological variability, lack of clinical validation, and cost barriers.
Rajeshwar Vodeti, V. Bakshi, Somasundaram Indirabanu et al.· Anti-Infective Agents· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.